ClinicalTrials.gg
Status unknownNCT05981170RAPASSUpdated Aug 8, 2023

Rurality Adapted Physical Activity Sport Health

An observational study in Brain Tumour and Metastatic Cancer, sponsored by Institut Cancerologie de l'Ouest. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-08-08.

Sponsored by Institut Cancerologie de l'Ouest · Observational

The sponsor has not verified this record recently (last verified May 2023), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
10
Ages
18 Years and older
Sex
All
01

Study summary

Physical activity (PA) has been an integral part of non-drug therapy since the early 2010s. This supportive care is likely to reduce fatigue and improve the quality of life of patients during and after the cancer treatment phase.

Physical activity also has a protective effect in terms of tertiary prevention by reducing the risk of recurrence of certain cancers (breast, colon, prostate) by around 40 to 50% and by reducing overall mortality.

Adapted physical activity (APA) is offered at the Institut de Cancérologie de l'Ouest (ICO) in Angers, but there are obstacles particularly linked to the geographical distance of the establishment where this activity is offered.

The RAPASS project is a prospective study which will be proposed to patients followed at the ICO, living in rural areas and far from Angers. Its main objective is to describe the fatigue and quality of life of patients before, during and after a 13-session home-based APA programme. The data collected will also be used to describe changes in physical condition and level, compliance with the programme, continuation of physical activity beyond the duration of the programme, and satisfaction.

Read the detailed description

The oncologist first assesses the patient's need for APA. The patient is then seen by the ICO's APA coach (EAPA) who presents the APA programme. If the patient agrees to participate, the coach assesses the patient's physical capacity in order to adapt the programme to their needs.

The programme is then carried out with the departmental sports for all committee 49.

The frequency of practice will ideally be one session per week at the patient's home, supervised by a coach from Departmental Committee for Sport for All in 49. A total of 13 sessions will be carried out.

The sessions will aim to develop all the components of physical fitness (endurance, strength, balance, flexibility, coordination, etc.).

The patient receives a walking logbook to record the number of daily steps taken, an exercise booklet to work independently and a pedometer.

In the presence of the coach, the patients perform different exercises and complete different questionnaires.

The programme is evaluated by the ICO EAPA 3 months after the 13th and final session.

02

Conditions studied

  • Brain Tumour
  • Metastatic Cancer

Keywords

  • Adapted physical activity
  • Rurality
  • Oncology
  • Physical fitness
  • Supportive care
03

In context

Brain Neoplasms

1,993 studies on the registry are indexed under Brain Neoplasms; 516 are open to participants now.

This study's planned enrollment of 10 is below the median of 100 across 389 observational studies indexed under Brain Neoplasms.

Browse Brain Neoplasms studies →

Lead sponsor

Institut Cancerologie de l'Ouest is the lead sponsor of 109 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients treated at the ICO Angers for a brain tumour and or metastatic cancer with medically measured APA needs.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Performans Status ≤ 2
  • Patient living in a rural area
  • Patient with a brain tumour and/or metastatic cancer
  • Patient with a medical prescription for APA practice
  • Patient with a certificate of no contraindication to physical activity

Exclusion criteria

Exclusion Criteria:

  • Persons deprived of their liberty, under court protection, under guardianship or under the authority of a guardian
  • Patient unable to undergo the trial procedures for social or psychological reasons
  • Patient who does not understand French
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
10 participants (estimated)
Patient registry
No

Interventions

  • OtherAdapted physical activity at home

    The programme will take place over 6 months and will include : 1 consultation with the oncologist who will first assess the need for Adapted Physical Activity and then prescribe the APA with a certificate of no physical contraindication 1 consultation with the ICO's APA coach who will present the APA programme and assess the patient's physical capacity using the Short Physical Performance Battery (SPPB) test in order to adapt the programme to their needs. 13 home-based APA sessions (ideally one session per week) with the EAPA from Departmental Committee for Sport for All in 49 1 telephone call with the EAPA of the ICO to evaluate the programme 3 months after the last session. Patients will also be asked to complete questionnaires at the first session (S1), halfway through the sessions (S6) and at the last session (S13). These are FACIT-F 5Functional Assessment of Chronic Illness Therapy - Fatigue ; Ricci and L. Gagnon ; P-GIC (Patients' Global Impression of Change (PGIC) scale)

06

What researchers measure

Primary outcomes

  1. Functional Assessment of Chronic Illness Therapy - Fatigue Scale (FACIT-F)

    To describe the fatigue (physical, functional, social, emotional components) of patients. The Score from FACIT-F range from 0 to 52. The higher the score, the lower is the fatigue.

    Time frame: Through study completion, an average 6 months.

Secondary outcomes

  1. Short Physical Performance Battery test (SPPB)

    It is used to assess the physical performance of an individual. It is the result of the scores of three criteria: the balance test, the walking speed test and the chair lift test. The sum of the scores of all the tests gives an overall performance score: * SPPB 0-6: Poor performance * SPPB 7-9: Intermediate performance * SPPB 10-12: High performance

    Time frame: Through studied intervention, an average 3 months.

  2. 6 minute walk test

    This test measures the functional limitation by comparing the theoretical distance with the measured distance. The patient is asked to walk as far as possible within six minutes: * Excellent functional mobility ≥91% of the theoretical distance * Good functional mobility between 82% and 90% of the theoretical distance * Moderate functional limitation between 74% and 82% of the theoretical distance * Severe functional limitation ≤73% of the theoretical distance

    Time frame: Through studied intervention, an average 3 months.

  3. Hand grip test

    This test measures muscular health of the hands and forearms.

    Time frame: Through studied intervention, an average 3 months.

  4. Flexibility test

    The patient performs a standing trunk flexion with legs stretched. Depending on the area reached (hand touching the ground, kick, tibia, etc.), a score will be given on a scale of 1 to 5, which differs according to the patient's sex.

    Time frame: Through studied intervention, an average 3 months.

  5. Balance test

    The patient is asked to stand on one leg for 1 minute with their eyes open. The best time is recorded and depending on the age and sex of the patient, his or her performance will be rated on a scale of 1 (very poor balance) to 4 (excellent balance).

    Time frame: Through studied intervention, an average 3 months.

  6. Ricci et Gagnon questionnaire

    This questionnaire assesses the level of physical activity. A number of points ranging from 1 to 5 are assigned to each answer. The total sum of the points determines an overall score that classifies the patients into : * Score \< 18 : inactive * 18 ≤ Score ≤ 35: active * Score \> 35: very active

    Time frame: Through study completion, an average 6 months.

  7. The Patient Global Impression scale (P-GIC)

    Evaluates the patient's satisfaction with the implementation of a home-based APA programme. The questionnaire includes a single question asking the patient what change home-based APA has had on their overall quality of life. The patient is given 7 options from which to choose the one that best corresponds to the perceived change: Very strongly positive, Strongly positive, Slightly positive, No change, Slightly negative, Strongly negative, Very strongly negative.

    Time frame: At the end of the APA sessions, on average 3 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 8, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05981170
Responsible party
Sponsor
First posted
Aug 8, 2023
Start date
Sep 2023 (estimated)
Primary completion
Mar 2025 (estimated)
Completion
Mar 2025 (estimated)
Last update
Aug 8, 2023

Study contacts

Loïc FAIVRE
Contact
loïc.faivre@ico.unicancer.fr
(0)2 41 35 27 00 ext. +33
Loïc FAIVRE
principal investigator · Institut de Cancérologie de l'Ouest

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion